NasdaqGS:IDXXMedical Equipment
The Bull Case For IDEXX Laboratories (IDXX) Could Change Following UK Launch Of Canine Cancer Dx Panel – Learn Why
On 1 April 2026, IDEXX Laboratories launched the IDEXX Cancer Dx Panel in the UK, offering a blood-based test for early detection of lymphoma in at-risk dogs via its reference laboratories, with results available in 3–5 business days and veterinarian pricing starting from £22.50.
The UK introduction builds on adoption by nearly 6,000 practices in North America and underscores IDEXX’s push to embed cancer screening into routine preventative care, supported by research showing strong pet owner...